Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: The coming of age

Seminars in Fetal and Neonatal Medicine

Volumn 16, Issue 2, 2011, Pages 88-93

  Chiu, Rossa W K ^a   Lo, Y M Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cell free fetal nucleic acids; Fetal aneuploidy; Monogenic diseases; Next generation sequencing; Non invasive prenatal diagnosis; Trisomy 21

Indexed keywords

DNA; DNA MARKER; RHESUS D ANTIGEN;

ANEUPLOIDY; ARTICLE; CELL FREE SYSTEM; CHROMOSOME 21; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; DNA SEQUENCE; EPIGENETICS; FETUS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MATERNAL AGE; MATERNAL PLASMA; MONOGENIC DISORDER; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SEX DETERMINATION; SPONTANEOUS ABORTION; TRISOMY 21; Y CHROMOSOME;

EID: 79951942977     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2010.10.003     Document Type: Article

References (47)

1. Alfirevic Z., Sundberg K., Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 2003, (3):CD003252.
2. Kagan K.O., Wright D., Baker A., Sahota D., Nicolaides K.H. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008, 31:618-624.
3. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005, 353:2001-2011.
4. Wapner R., Thom E., Simpson J.L., et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003, 349:1405-1413.
5. Weatherall D.J. Thalassaemia: the long road from bedside to genome. Nat Rev Genet 2004, 5:625-631.
6. Cheung M.C., Goldberg J.D., Kan Y.W. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet 1996, 14:264-268.
7. Rust D.W., Bianchi D.W. Microchimerism in endocrine pathology. Endocr Pathol 2009, 20:11-16.
8. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22:609-615.
9. Lo Y.M.D., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
10. Lo Y.M.D., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62:768-775.
11. Lun F.M.F., Chiu R.W.K., Chan K.C.A., Leung T.Y., Lau T.K., Lo Y.M.D. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008, 54:1664-1672.
12. Galbiati S., Smid M., Gambini D., et al. Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 2005, 117:243-248.
13. Lo Y.M.D., Zhang J., Leung T.N., Lau T.K., Chang A.M., Hjelm N.M. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999, 64:218-224.
14. Lui Y.Y., Woo K.S., Wang A.Y., et al. Origin of plasma cell-free DNA after solid organ transplantation. Clin Chem 2003, 49:495-496.
15. Costa J.M., Benachi A., Gautier E. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002, 346:1502.
16. Wright C.F., Burton H. The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 2009, 15:139-151.
17. Scheffer P.G., van der Schoot C.E., Page-Christiaens G.C., Bossers B., van Erp F., de Haas M. Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 2010, 115:117-126.
18. Rijnders R.J., van der Schoot C.E., Bossers B., de Vroede M.A., Christiaens G.C. Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 2001, 98:374-378.
19. Lo Y.M.D., Hjelm N.M., Fidler C., et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998, 339:1734-1738.
20. Faas B.H., Beuling E.A., Christiaens G.C., von dem Borne A.E., van der Schoot C.E. Detection of fetal RHD-specific sequences in maternal plasma. Lancet 1998, 352:1196. [letter].
21. Finning K., Martin P., Summers J., Massey E., Poole G., Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008, 336:816-818.
22. Van der Schoot C.E., Hahn S., Chitty L.S. Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin Fetal Neonatal Med 2008, 13:63-68.
23. Page-Christiaens G.C., Bossers B., Van der Schoot C.E., De Haas M. Use of bi-allelic insertion/deletion polymorphisms as a positive control for fetal genotyping in maternal blood: first clinical experience. Ann NY Acad Sci 2006, 1075:123-129.
24. Chow K.C.K., Chiu R.W.K., Tsui N.B.Y., et al. Mass spectrometric detection of an SNP panel as an internal positive control for fetal DNA analysis in maternal plasma. Clin Chem 2007, 53:141-142.
25. Ng E.K.O., Tsui N.B.Y., Lau T.K., et al. mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 2003, 100:4748-4753.
26. Chim S.S.C., Tong Y.K., Chiu R.W.K., et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 2005, 102:14753-14758.
27. Grunau C., Clark S.J., Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001, 29:E65.
28. Chiu R.W.K., Chim S.S.C., Wong I.H.N., et al. Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007, 170:941-950.
29. Chan K.C.A., Ding C., Gerovassili A., et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006, 52:2211-2218.
30. Saito H., Sekizawa A., Morimoto T., Suzuki M., Yanaihara T. Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 2000, 356:1170. [letter].
31. Chiu R.W.K., Lau T.K., Cheung P.T., Gong Z.Q., Leung T.N., Lo Y.M.D. Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 2002, 48:778-780.
32. Chiu R.W.K., Lau T.K., Leung T.N., Chow K.C.K., Chui D.H.K., Lo Y.M.D. Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 2002, 360:998-1000.
33. Ding C., Chiu R.W.K., Lau T.K., et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci USA 2004, 101:10762-10767.
34. Tsang J.C.H., Charoenkwan P., Chow K.C.K., et al. Mass spectrometry-based detection of hemoglobin E mutation by allele-specific base extension reaction. Clin Chem 2007, 53:2205-2209.
35. Lun F.M.F., Tsui N.B.Y., Chan K.C.A., et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:19920-19925.
36. Vogelstein B., Kinzler K.W. Digital PCR. Proc Natl Acad Sci USA 1999, 96:9236-9241.
37. Chiu R.W.K., Cantor C.R., Lo Y.M.D. Non-invasive prenatal diagnosis by single molecule counting technologies. Trends Genet 2009, 25:324-331.
38. Lo Y.M.D., Tsui N.B.Y., Chiu R.W.K., et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007, 13:218-223.
39. Go A.T., Visser A., Betsalel O.T., van Vugt J.M., Blankenstein M.A., Oudejans C.B. Measurement of allelic-expression ratios in trisomy 21 placentas by quencher extension of heterozygous samples identified by partially denaturing HPLC. Clin Chem 2008, 54:437-440.
40. Tong Y.K., Ding C., Chiu R.W.K., et al. Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 2006, 52:2194-2202.
41. Tong Y.K., Jin S., Chiu R.W.K., et al. Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 2010, 56:90-98.
42. Lo Y.M.D., Lun F.M.F., Chan K.C.A., et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007, 104:13116-13121.
43. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008, 105:16266-16271.
44. Chiu R.W.K., Chan K.C.A., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008, 105:20458-20463.
45. Chiu R.W.K., Sun H., Akolekar R., et al. Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010, 56:459-463.
46. Fan H.C., Quake S.R. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS One 2010, 5:e10439.
47. Pettersson E., Lundeberg J., Ahmadian A. Generations of sequencing technologies. Genomics 2009, 93:105-111.